Metabolic Profiling of Obesity With and Without the Metabolic Syndrome - A Multi-Sample Evaluation : Supplementary material

Pdf file with a total of 5 Supplementary Tables:

Supplementary Table 1. An overview of metabolite differences between certain groups.
Supplementary Table 2. Pathway enrichment and topographical analysis for the 427 validated metabolites that differed between obese subjects without MetS and normal-weight without MetS.
Supplementary Table 3. Pathway enrichment and topographical analysis for the 196 validated metabolites that differed between obese subjects with and without MetS.
Supplementary Table 4. Relationships between metabolites and BMI and number of MetS components in the continuous analysis.
Supplementary Table 5. Pathway enrichment and topographical analysis for the 371 validated metabolites that differed between overweight subjects without MetS and normal-weight without MetS.
Supplementary Table 6. Pathway enrichment and topographical analysis for the 417 metabolites being related to BMI in subjects with no MetS components.

Pdf file revised 211202. The old version is archived.

The dataset was originally published in DiVA and moved to SND in 2024.

本数据集为PDF格式文件，共包含6份补充表格：
补充表1. 特定组别间代谢物差异概况。
补充表2. 针对无代谢综合征（Metabolic Syndrome, MetS）的肥胖受试者与无代谢综合征的体重正常受试者之间存在差异的427种经验证的代谢物的通路富集与拓扑分析。
补充表3. 针对伴与不伴代谢综合征的肥胖受试者之间存在差异的196种经验证的代谢物的通路富集与拓扑分析。
补充表4. 连续型分析中代谢物与身体质量指数（Body Mass Index, BMI）及代谢综合征组分数量之间的关联关系。
补充表5. 针对无代谢综合征的超重受试者与无代谢综合征的体重正常受试者之间存在差异的371种经验证的代谢物的通路富集与拓扑分析。
补充表6. 针对无代谢综合征组分的受试者中与身体质量指数相关的417种代谢物的通路富集与拓扑分析。

本PDF文件于2021年12月2日完成修订，旧版本已存档。

本数据集最初发表于DiVA，并于2024年迁移至SND。